|
UBE2I expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
9.67869999701776E-08 |
| Normal-vs-Stage3 |
6.43540776223972E-12 |
| Normal-vs-Stage4 |
3.197600E-04 |
| Stage1-vs-Stage2 |
7.929800E-01 |
| Stage1-vs-Stage3 |
3.105800E-02 |
| Stage1-vs-Stage4 |
1.768220E-02 |
| Stage2-vs-Stage3 |
1.679760E-01 |
| Stage2-vs-Stage4 |
8.517800E-02 |
| Stage3-vs-Stage4 |
3.973400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62436730732907E-12 |
| Normal-vs-AfricanAmerican |
1.62758695410048E-12 |
| Normal-vs-Asian |
1.08119999997491E-06 |
| Caucasian-vs-AfricanAmerican |
2.220100E-02 |
| Caucasian-vs-Asian |
4.490000E-01 |
| AfricanAmerican-vs-Asian |
9.713400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
9.047400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.08449915714459E-11 |
| Normal-vs-Extreme_Weight |
1.62447832963153E-12 |
| Normal-vs-Obese |
1.62447832963153E-12 |
| Normal-vs-Extreme_Obese |
1.176160E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.698200E-01 |
| Normal_Weight-vs-Obese |
2.504400E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.431400E-01 |
| Extreme_Weight-vs-Obese |
9.161400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.691600E-02 |
| Obese-vs-Extreme_Obese |
4.958000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.70370000329712E-08 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
4.56199999998574E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.903600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.938300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.380800E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.612240E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.220200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.689600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
<1E-12 |
| Normal-VS-Type2 PRCC |
3.28159721618704E-12 |
| Normal-VS-KIRP CIMP |
1.51690000005367E-07 |
| Normal-VS-Unclassified PRCC |
6.57773835399666E-12 |
| Type1 PRCC-VS-Type2 PRCC |
1.85149999998302E-06 |
| Type1 PRCC-VS-KIRP CIMP |
2.213100E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
6.874400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.05979999998063E-07 |
| Type2 PRCC-VS-Unclassified PRCC |
5.863900E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.156390E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.68778357745714E-12 |
| Normal-vs-N1 |
3.99309474374832E-11 |
| Normal-vs-N2 |
1.596320E-02 |
| N0-vs-N1 |
2.280200E-03 |
| N0-vs-N2 |
6.475700E-02 |
| N1-vs-N2 |
7.124800E-01 |
|
|
